Cargando…
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy
The human CD19 antigen is a 95 kd transmembrane glycoprotein belonging to the immunoglobulin superfamily. CD19 is classified as a type I transmembrane protein, with a single transmembrane domain, a cytoplasmic C-terminus, and extracellular N-terminus. CD19 is a biomarker for normal and neoplastic B...
Autores principales: | Wang, Kemeng, Wei, Guoqing, Liu, Delong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520838/ https://www.ncbi.nlm.nih.gov/pubmed/23210908 http://dx.doi.org/10.1186/2162-3619-1-36 |
Ejemplares similares
-
Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012) -
Diagnosis and treatment of CD20 negative B cell lymphomas
por: Katchi, Tasleem, et al.
Publicado: (2017) -
SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma
por: Narurkar, Roshni, et al.
Publicado: (2016) -
Clinical development of anti‐CD19 chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma
por: Makita, Shinichi, et al.
Publicado: (2017) -
Anti-CD19 CAR T-Cell Therapy for Adult Patients With Refractory Large B-Cell Lymphoma
por: McDermott, Kathleen, et al.
Publicado: (2019)